SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on: December 17,2023

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on:December 17,2023

New technology in recent clinical study aims toward earlier detection of hepatocellular carcinoma

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainPrimary liver cancer, the third-leading cause of cancer-related death worldwide, takes more than 30,000 lives in the Unite

Updated on: December 18,2023

New technology in recent clinical study aims toward earlier detection of hepatocellular carcinoma

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainPrimary liver cancer, the third-leading cause of cancer-related death worldwide, takes more than 30,000 lives in the Unite

Updated on:December 18,2023

Study finds African Americans with cancer at higher risk for blood clots

byBoston University School of MedicineCredit: CC0 Public DomainAfrican-Americans are at higher risk for cancer-associated venous thromboembolism (VTE) as compared with patients from other races.

Updated on: December 22,2023

Study finds African Americans with cancer at higher risk for blood clots

byBoston University School of MedicineCredit: CC0 Public DomainAfrican-Americans are at higher risk for cancer-associated venous thromboembolism (VTE) as compared with patients from other races.

Updated on:December 22,2023

Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

September 22, 2023Chris RyanTreatment with the combination of enfortumab Vedotin and pembrolizumab led to an improvement in overall survival and progression-free survival compared with chemotherapy in

Updated on: October 15,2023

Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

September 22, 2023Chris RyanTreatment with the combination of enfortumab Vedotin and pembrolizumab led to an improvement in overall survival and progression-free survival compared with chemotherapy in

Updated on:October 15,2023

Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me

Updated on: June 11,2024

Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me

Updated on:June 11,2024

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

In a study published inCancer Discovery, researchers from Canada tested the use of a multimodal liquid biopsy assay based on cell-free DNA (cfDNA) for early cancer detection in patients with Li-

Updated on: October 30,2023

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

In a study published inCancer Discovery, researchers from Canada tested the use of a multimodal liquid biopsy assay based on cell-free DNA (cfDNA) for early cancer detection in patients with Li-

Updated on:October 30,2023

US approves sickle cell breakthrough with gene editing therapy

Credit: Unsplash/CC0 Public DomainThe United States on Friday approved a breakthrough therapy that uses revolutionary gene editing tool CRISPR to treat the debilitating blood disorder sickle cell dise

Updated on: January 02,2024

US approves sickle cell breakthrough with gene editing therapy

Credit: Unsplash/CC0 Public DomainThe United States on Friday approved a breakthrough therapy that uses revolutionary gene editing tool CRISPR to treat the debilitating blood disorder sickle cell dise

Updated on:January 02,2024

New fast, effective way to detect cancer stem cells

New fast, effective way to detect cancer stem cellsby Fram Dinshaw,McMaster UniversityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101108McMaster

Updated on: October 28,2023

New fast, effective way to detect cancer stem cells

New fast, effective way to detect cancer stem cellsby Fram Dinshaw,McMaster UniversityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101108McMaster

Updated on:October 28,2023

Squamous cell carcinoma study: Cancer stem cells are fueled through dialogue with their

Squamous cell carcinoma study: Cancer stem cells are fueled through dialogue with their environmentsbyRockefeller UniversityTGF beta signaling (red) is one way that the environment causes cancer

Updated on: October 29,2023

Squamous cell carcinoma study: Cancer stem cells are fueled through dialogue with their

Squamous cell carcinoma study: Cancer stem cells are fueled through dialogue with their environmentsbyRockefeller UniversityTGF beta signaling (red) is one way that the environment causes cancer

Updated on:October 29,2023

Early disease detection in body fluids using photonic biosensors

by Anne-Julie Zichner, Fraunhofer-Institut für Photonische Mikrosysteme (IPMS)Photonic biosensor chip of Fraunhofer IPMS Credit: Fraunhofer IPMSStandard medical procedures are often time-consuming and

Updated on: August 08,2024

Early disease detection in body fluids using photonic biosensors

by Anne-Julie Zichner, Fraunhofer-Institut für Photonische Mikrosysteme (IPMS)Photonic biosensor chip of Fraunhofer IPMS Credit: Fraunhofer IPMSStandard medical procedures are often time-consuming and

Updated on:August 08,2024

How intestinal cancer stem cells evade anti-angiogenic therapy

How intestinal cancer stem cells evade anti-angiogenic therapybyLudwig Cancer ResearchCredit: CC0 Public DomainA team led by Ludwig Lausanne's Tatiana Petrova, Jeremiah Bernier-Latmani and a

Updated on: October 30,2023

How intestinal cancer stem cells evade anti-angiogenic therapy

How intestinal cancer stem cells evade anti-angiogenic therapybyLudwig Cancer ResearchCredit: CC0 Public DomainA team led by Ludwig Lausanne's Tatiana Petrova, Jeremiah Bernier-Latmani and a

Updated on:October 30,2023

What you should know about thyroid cancer in adolescents, young adults

by Deb BalzerCredit: Pixabay/CC0 Public DomainCancer is often thought of as a disease that affects older people, and with the median age of a cancer diagnosis at 66 years, it does. But cancer can be d

Updated on: December 23,2023

What you should know about thyroid cancer in adolescents, young adults

by Deb BalzerCredit: Pixabay/CC0 Public DomainCancer is often thought of as a disease that affects older people, and with the median age of a cancer diagnosis at 66 years, it does. But cancer can be d

Updated on:December 23,2023